Literature DB >> 8095283

Inactivation and mutation induction in V79 cells by low energy protons: re-evaluation of the results at the LNL facility.

M Belli1, F Cera, R Cherubini, A M Haque, F Ianzini, G Moschini, O Sapora, G Simone, M A Tabocchini, P Tiveron.   

Abstract

During the upgrading of the radiobiological facility at the Laboratori Nazionali di Legnaro (LNL) we found that uncorrected values of the proton energy were used in the past. This circumstance prompted us to perform the re-evaluation of the physical parameters for all the proton beams used in our previous radiobiological investigations (Belli et al. 1987) and, subsequently, the re-evaluation of all our previous dose-response curves for inactivation and mutation induction (Belli et al. 1989, 1991). This re-evaluation leads to significant changes in the dose-response curves and in the RBE-LET relationships only at the two lowest energies (highest LET) used. These two points are not reliable for the identification of a peak in RBE-LET relationship for cell inactivation. In spite of that, the extent of the changes is not such as to modify the general conclusion previously drawn, pointing out that there is a LET range where protons are more effective than alpha-particles.

Mesh:

Substances:

Year:  1993        PMID: 8095283     DOI: 10.1080/09553009314550441

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  10 in total

1.  Calculation of the inactivation cross section of v79 cells by protons in radiotherapy.

Authors:  Faika A Azooz; Thamer J Alkhalidy
Journal:  Sultan Qaboos Univ Med J       Date:  2007-12

2.  The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.

Authors:  Ariungerel Gerelchuluun; Eri Manabe; Takaaki Ishikawa; Lue Sun; Kazuya Itoh; Takeji Sakae; Kenshi Suzuki; Ryoichi Hirayama; Aroumougame Asaithamby; David J Chen; Koji Tsuboi
Journal:  Radiat Res       Date:  2015-03-04       Impact factor: 2.841

3.  Comparison of radiobiological effective depths in 65-MeV modulated proton beams.

Authors:  J T Tang; T Inoue; T Inoue; H Yamazaki; S Fukushima; N Fournier-Bidoz; M Koizumi; S Ozeki; K Hatanaka
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

5.  Proton Relative Biological Effectiveness - Uncertainties and Opportunities.

Authors:  Harald Paganetti
Journal:  Int J Part Ther       Date:  2018-09-21

6.  In Silico Non-Homologous End Joining Following Ion Induced DNA Double Strand Breaks Predicts That Repair Fidelity Depends on Break Density.

Authors:  N T Henthorn; J W Warmenhoven; M Sotiropoulos; R I Mackay; N F Kirkby; K J Kirkby; M J Merchant
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

7.  Geometrical Properties of the Nucleus and Chromosome Intermingling Are Possible Major Parameters of Chromosome Aberration Formation.

Authors:  Floriane Poignant; Ianik Plante; Zarana S Patel; Janice L Huff; Tony C Slaba
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

8.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation.

Authors:  Thomas Friedrich; Uwe Scholz; Thilo Elsässer; Marco Durante; Michael Scholz
Journal:  J Radiat Res       Date:  2012-12-23       Impact factor: 2.724

9.  Relative Biological Effectiveness of HZE Particles for Chromosomal Exchanges and Other Surrogate Cancer Risk Endpoints.

Authors:  Eliedonna Cacao; Megumi Hada; Premkumar B Saganti; Kerry A George; Francis A Cucinotta
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

10.  Biological Effectiveness of Accelerated Protons for Chromosome Exchanges.

Authors:  Kerry A George; Megumi Hada; Francis A Cucinotta
Journal:  Front Oncol       Date:  2015-10-19       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.